On Sept. 29, 2003, $81 million was awarded by National Institute of Allergy and Infectious Diseases (NIAID) through…
On Sept. 16, 2003, The Allen Institute for Brain Science, a division of the Allen Institute, was established…
On Sept. 4, 2003, the National Center for Research Resources (NCCR) awarded a $6.7 million grant to the…
On Sept. 3, 2003, the death rates from the four most common cancers, – lung, breast, prostate, and…
On Aug. 25, 2003, the FDA approved an expanded indication for ENBREL (etanercept) to inhibit the progression of…
On Aug. 17, 2003, Oregon Health & Science University (OHSU) announced the final results of a smallpox vaccine…
On Jul. 17, 2003, the results from the Prostate Cancer Prevention Trial (PCPT) were published in New England…
On Jul. 11, 2003, the U.S. Food and Drug Administration (FDA) published a final rule in the Federal…
On Jul. 10, 2003, the University Fertility Consultants at Oregon Health & Science University (OHSU) announced they had…
On Jul. 8, 2003, the U.S. Centers for Disease Control and Prevention (CDC) responded to U.S. outbreak of…
On Jul. 2, 2003, Invitrogen bought Molecular Probes for $325 million in cash. The company became part of…
In Jul. 2003, HB 3613 was passed in the Oregon State Legislature and enacted a mandate for the…
In July 2003, University of Saskatchewan researchers announced they had discovered “follicular waves” in the human menstrual cycle….
On Jun. 24, 2003, results of the Prostate Cancer Prevention Trial (PCPT), testing the effectiveness of finasteride to…
On Jun. 20, 2003, NanoString Technologies was incorporated in Seattle as a spin-off from the Institute for Systems…
On Jun. 20, 2003, Genentech drug Xolair (omalizumab) was approved by the U. S. Food and Drug Administration…
On Jun. 17, 2003, the first nasally administered influenza vaccine (FluMist by MedImmune) was licensed. This live influenza…
On Jun. 16, 2003, researchers at Stanford University Medical Center announced they found that a drug commonly prescribed…
On Jun. 5, 2003, data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial gave fresh insight…
On May 30, 2003, the Attorney General of California consented to the sale of the assets of the…
On May 28, 2003, the world’s first cloned horse named Prometea was born at the Laboratory of Reproductive…
On May 22, 2003, Amgen announced it was relocating its cancer research division to Seattle following its acquisition…
On May 13, 2003, the FDA approved the drug bortezomib (Velcade) for the treatment of multiple myeloma. In…
On May 4, 2003, University of Idaho-Utah State University researchers became the first in the world to clone…
On May 1, 2003, Mark Haddon’s The Curious Incident of the Dog in the Night-Time was published, allowing…
On Apr. 27, 2003, Stanford researchers found that Wnt genes, first discovered as critical genes in cancer, are…
On Apr. 24, 2003, the National Cancer Institute, CDC, AHRQ, and SAMHSA, in collaboration with the American Cancer…
On Apr. 23, 2003, Dr. Vincent Poitout at the Pacific Northwest Research Foundation (PNRF) won the Thomas R….
On Apr. 15, 2003, the National Heart Lung Blood Institute (NHLB) announced a $37 million trial, coordinated by…
On Apr. 14, 2003, The International Human Genome Sequencing Consortium, led in the U.S. the National Human Genome…